ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

Condition: Hereditary Transthyretin Amyloidosis (hATTR)

In The News Cardiovascular Disease Burden Before Hereditary Transthyretin Amyloidosis Diagnosis Among Medicare Beneficiaries
In The News Cardiovascular Disease Burden Before Hereditary Transthyretin Amyloidosis Diagnosis
In The News Use of Commercial Claims Data to Estimate Hereditary Transthyretin-Mediated Amyloidosis Prevalence and Incidence in the US
In The News Symptom Burden and Healthcare Utilization Before Diagnosis of Transthyretin-Mediated Amyloidosis Among Medicare Beneficiaries
In The News The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis
In The News Cardiovascular Burden Prior to Diagnosis of Hereditary Transthyretin Amyloidosis
In The News The Patient Journey Prior to Diagnosis of Hereditary Transthyretin Amyloidosis
In The News The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data
In The News Cardiovascular Burden Prior to Diagnosis of Hereditary Transthyretin Amyloidosis

Posts pagination

1 2 Next page >
© 2026
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health